all crypto Related searches

Pacific Securities: Goldwind Technology's performance is expected to achieve rapid growth, with the first "buy" rating. Pacific Securities Research Report pointed out that with the profit recovery of wind turbine business and the contribution of wind farm investment and development and wind power service business, Goldwind Technology's (002202.SZ) performance is expected to achieve rapid growth. The first coverage gives a "buy" rating. Goldwind Technology has ranked first in the domestic wind power market for 13 consecutive years since 2011; However, in recent years, under the strong competitive pressure of wind turbine enterprises after the second line, their market share has declined. In the future, with the increase of market concentration, Goldwind Technology, as a leader, is expected to increase its share. At the end of the third quarter of 2024, the company's external order volume was 41.38GW, and sufficient in-hand order volume supported its share increase.China Seismological Network officially measured that a magnitude 3.1 earthquake occurred at 17: 09 on December 13th in Kuqa City, Aksu Prefecture, Xinjiang (41.23 degrees north latitude and 83.31 degrees east longitude) with a focal depth of 21 kilometers.Shenzhen Airport cooperated with China Airlines to build the first domestic civil aviation international transit service system. According to Shenzhen Airport, the first domestic civil aviation international transit service system jointly built by Shenzhen Airport and China Airlines was officially released recently. The system is dedicated to solving the problems of data barriers and information blind spots in the supervision of international transit passengers and luggage, which will effectively improve the security efficiency of international through flights and international transit passengers and further enhance the competitiveness of Shenzhen Airport International Aviation Hub.

Russian Defense Ministry: Russian air defense forces shot down 13 Ukrainian drones in Kursk, Belgorod, Rostov and Lipetsk last night.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.Four departments: By 2027, the digital transformation of specialized and innovative small and medium-sized enterprises should be completely reformed. The Ministry of Industry and Information Technology, the Ministry of Finance, the People's Bank of China and the General Administration of Financial Supervision issued the Special Action Plan for Digital Empowerment of Small and Medium-sized Enterprises (2025-2027). According to the notice, by 2027, the "100-city" pilot project for the digital transformation of small and medium-sized enterprises has achieved solid results, and the digital transformation of specialized and special small and medium-sized enterprises should be completely reformed, forming a number of transformation benchmarks with a digital level of three or four; The digital level of the pilot provincial-level specialized and innovative small and medium-sized enterprises has reached the second level and above, and the numerical control rate of key processes of industrial small and medium-sized enterprises in the country has reached 75%; The cloud access rate of small and medium-sized enterprises exceeds 40%. Initially build a digital transformation ecology of small and medium-sized enterprises, which is coordinated by the Ministry and the province, the integration of large and medium-sized enterprises, the adaptation of supply and demand in key scenes, and the strong public service guarantee, and empower small and medium-sized enterprises to specialize in special new development.

The financial technology companies supported by Wal-Mart are valued at $2.5 billion. The traditional banking industry is under threat. Wal-Mart is injecting more funds into its newly-started financial start-ups, obtaining a valuation of $2.5 billion for this company, and indicating its ambition to further set foot in the financial services industry. According to informed sources, the world's largest retailer is jointly leading the financing of more than 300 million US dollars with investment company Ribbit Capital. This marks a new valuation for the company named One, in which Wal-Mart holds a majority stake. Wal-Mart has been providing products to many customers and employees in order to gain a greater foothold in the field of financial services. For the financial industry, the threat of Wal-Mart and other companies encroaching on its territory is getting closer and closer. Just last year, JPMorgan Chase CEO Jamie Dimon mentioned the competitive threat of Wal-Mart and other enterprises, pointing out that its hundreds of millions of customers and huge resources at its disposal were "extraordinary competitive advantages".Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.Helen Piano's profit distribution plan for the first three quarters: it is planned to distribute 0.32 yuan for 10 shares, and Helen Piano (300329) released the profit distribution plan for the first three quarters of 2024 on the evening of December 13, and it is planned to distribute a cash dividend of 0.32 yuan (including tax) to all shareholders for every 10 shares, with an estimated cash dividend of 8,092,400 yuan.